Aikaterini Smaragdi Papadopoulou

Aikaterini Smaragdi Papadopoulou

Auto-generated profile, based on publicly available information

Aikaterini Smaragdi Papadopoulou

Huntington’s Disease Centre and Department of Neurodegenerative Disease, Queen Square Institute of Neurology, UCL, London WC1N 3BG, UK

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2008 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SHSébastien S. Hébert
Sébastien S. Hébert
KHKatrien Horré
Katrien Horré
LNLaura Nicolaï
Laura Nicolaï
APAikaterini S. Papadopoulou
Aikaterini S. Papadopoulou
WMWim Mandemakers
Wim Mandemakers
BSBart De Strooper
Bart De Strooper
Although the role of APP and PSEN genes in genetic Alzheimer's disease (AD) cases is well established, fairly little is known about the molecular mechanisms affecting Aβ generation in sporadic AD. Deficiency in Aβ clearance is certainly a possibility, but increased expression of proteins like APP or BACE1/β-secretase may also be associated with the disease. We therefore investigated changes in microRNA (miRNA) expression profiles of sporadic AD patients and found that several miRNAs potentially involved in the regulation of APP and BACE1 expression appeared to be decreased in diseased brain. We show here that miR-29a, -29b-1, and -9 can regulate BACE1 expression in vitro . The miR-29a/b-1 cluster was significantly (and AD-dementia-specific) decreased in AD patients displaying abnormally high BACE1 protein. Similar correlations between expression of this cluster and BACE1 were found during brain development and in primary neuronal cultures. Finally, we provide evidence for a potential causal relationship between miR-29a/b-1 expression and Aβ generation in a cell culture model. We propose that loss of specific miRNAs can contribute to increased BACE1 and Aβ levels in sporadic AD.

9 September 2013 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
PLPierre Lau
Pierre Lau
KBKoen Bossers
Koen Bossers
RJRekin'S Janky
Rekin'S Janky
ESEvgenia Salta
Evgenia Salta
CFCarlo Sala Frigerio
Carlo Sala Frigerio
BSBart De Strooper
Bart De Strooper
An overview of miRNAs altered in Alzheimer's disease (AD) was established by profiling the hippocampus of a cohort of 41 late‐onset AD (LOAD) patients and 23 controls, showing deregulation of 35 miRNAs. Profiling of miRNAs in the prefrontal cortex of a second independent cohort of 49 patients grouped by Braak stages revealed 41 deregulated miRNAs. We focused on miR‐132‐3p which is strongly altered in both brain areas. Downregulation of this miRNA occurs already at Braak stages III and IV, before loss of neuron‐specific miRNAs. Next‐generation sequencing confirmed a strong decrease of miR‐132‐3p and of three family‐related miRNAs encoded by the same miRNA cluster on chromosome 17. Deregulation of miR‐132‐3p in AD brain appears to occur mainly in neurons displaying Tau hyper‐phosphorylation. We provide evidence that miR‐132‐3p may contribute to disease progression through aberrant regulation of mRNA targets in the Tau network. The transcription factor (TF) FOXO1a appears to be a key target of miR‐132‐3p in this pathway.

1 March 2009 in Neurobiology of Disease
Verified
Journal Article
Closed access
SHSébastien S. Hébert
Sébastien S. Hébert
KHKatrien Horré
Katrien Horré
LNLaura Nicolaï
Laura Nicolaï
BBBruno Bergmans
Bruno Bergmans
APAikaterini S. Papadopoulou
Aikaterini S. Papadopoulou
BSBart De Strooper
Bart De Strooper

21 July 2010 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
SHSébastien S. Hébert
Sébastien S. Hébert
APAikaterini S. Papadopoulou
Aikaterini S. Papadopoulou
PSPascal Smith
Pascal Smith
MGMarie-Christine Galas
Marie-Christine Galas
EPEmmanuel Planel
Emmanuel Planel
BSBart De Strooper
Bart De Strooper
Type III RNase Dicer is responsible for the maturation and function of microRNA (miRNA) molecules in the cell. It is now well-documented that Dicer and the fine-tuning of the miRNA gene network are important for neuronal integrity. However, the underlying mechanisms involved in neuronal death, particularly in the adult brain, remain poorly defined. Here we show that the absence of Dicer in the adult forebrain is accompanied by a mixed neurodegenerative phenotype. Although neuronal loss is observed in the hippocampus, cellular shrinkage is predominant in the cortex. Interestingly, neuronal degeneration coincides with the hyperphosphorylation of endogenous tau at several epitopes previously associated with neurofibrillary pathology. Transcriptome analysis of enzymes involved in tau phosphorylation identified ERK1 as one of the candidate kinases responsible for this event in vivo. We further demonstrate that miRNAs belonging to the miR-15 family are potent regulators of ERK1 expression in mouse neuronal cells and co-expressed with ERK1/2 in vivo. Finally, we show that miR-15a is specifically downregulated in Alzheimer's disease brain. In summary, these results support the hypothesis that changes in the miRNA network may contribute to a neurodegenerative phenotype by affecting tau phosphorylation.

20 November 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
YSYassine Sassi
Yassine Sassi
PAPetros Avramopoulos
Petros Avramopoulos
DRDeepak Ramanujam
Deepak Ramanujam
LGLaurenz Grüter
Laurenz Grüter
SWStanislas Werfel
Stanislas Werfel
SEStefan Engelhardt
Stefan Engelhardt
Chronic cardiac stress induces pathologic hypertrophy and fibrosis of the myocardium. The microRNA-29 (miR-29) family has been found to prevent excess collagen expression in various organs, particularly through its function in fibroblasts. Here, we show that miR-29 promotes pathologic hypertrophy of cardiac myocytes and overall cardiac dysfunction. In a mouse model of cardiac pressure overload, global genetic deletion of miR-29 or antimiR-29 infusion prevents cardiac hypertrophy and fibrosis and improves cardiac function. Targeted deletion of miR-29 in cardiac myocytes in vivo also prevents cardiac hypertrophy and fibrosis, indicating that the function of miR-29 in cardiac myocytes dominates over that in non-myocyte cell types. Mechanistically, we found cardiac myocyte miR-29 to de-repress Wnt signaling by directly targeting four pathway factors. Our data suggests that, cell- or tissue-specific antimiR-29 delivery may have therapeutic value for pathological cardiac remodeling and fibrosis.

18 December 2011 in Nature Immunology
Verified
Journal Article
Open access
PDF file
APAikaterini S Papadopoulou
Aikaterini S Papadopoulou
JDJames Dooley
James Dooley
MLMichelle A Linterman
Michelle A Linterman
WPWim Pierson
Wim Pierson
OUOlga Ucar
Olga Ucar
ALAdrian Liston
Adrian Liston
Interferon-α is a critical mediator of pathogen-induced thymic involution. Liston and colleagues show that the microRNA miR-29a reduces sensitivity of thymic epithelium to infection signals and protects against thymus involution. Thymic output is a dynamic process, with high activity at birth punctuated by transient periods of involution during infection. Interferon-α (IFN-α) is a critical molecular mediator of pathogen-induced thymic involution, yet despite the importance of thymic involution, relatively little is known about the molecular integrators that establish sensitivity. Here we found that the microRNA network dependent on the endoribonuclease Dicer, and specifically microRNA miR-29a, was critical for diminishing the sensitivity of the thymic epithelium to simulated infection signals, protecting the thymus against inappropriate involution. In the absence of Dicer or the miR-29a cluster in the thymic epithelium, expression of the IFN-α receptor by the thymic epithelium was higher, which allowed suboptimal signals to trigger rapid loss of thymic cellularity.